| Patents for C07D 279 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms (5,149) |
|---|
| 03/29/2006 | CN1753866A Arylcycloalkyl derivatives having branched side chains used as ppar receptor regulator, processes for their preparation and their use as pharmaceuticals |
| 03/29/2006 | CN1247553C 2-imino-1,3-thiazine derivs. |
| 03/28/2006 | US7019024 Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
| 03/28/2006 | CA2120374C 9-[(substituted glycyl) amido]-6-(substituted)-5-hydroxy-6-deoxytetracyclines |
| 03/23/2006 | DE102004044827A1 Jod-phenylsubstituierte cyclische Ketoenole Iodine-substituted cyclic ketoenols |
| 03/22/2006 | EP1636384A2 Gene amplification and overexpression in cancer |
| 03/22/2006 | EP1635909A2 Treatment of amyloid- and epileptogenesis-associated diseases |
| 03/21/2006 | US7015217 Cyclic sulfone derivatives as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE) |
| 03/21/2006 | CA2178949C Morpholine and thiomorpholine tachykinin receptor antagonists |
| 03/16/2006 | US20060058302 Antiinflammatory agents; osteoporosis; rheumatic diseases; autoimmune diseases; example compound: 2-Chloro-5-(3,5-dioxo-4,5-dihydro-3H-[1,2,4]triazin-2-yl)-N-(2-ethyl-hexyl)-benzamide |
| 03/15/2006 | EP0997147B1 Amino acid derivatives |
| 03/14/2006 | CA2250731C In vivo stain composition, process of manufacture, and methods of use to identify dysplastic tissue |
| 03/09/2006 | US20060052371 2-(3-cyanophenyl)-4H-1,3-benzothiazin-4-one; cardiovascular, bone or joint diseases, infectious, inflammatory, kidney diseases; safe and good effects of cell death inhibition, Migration Inhibitory Factor (MIF) binding |
| 03/09/2006 | US20060051690 Aromatic heterocyclic-based charge transport materials having two amino groups |
| 03/08/2006 | EP1632477A1 Benzamide derivative or salt thereof |
| 03/08/2006 | EP1631560A2 C-fms kinase inhibitors |
| 03/08/2006 | EP1631542A1 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof |
| 03/08/2006 | CN1244576C Chemical compounds |
| 03/07/2006 | US7008613 technetium labelled complexes; for the treatment or diagnosis of pathologies caused by attack on human cartilage, arthritis |
| 03/02/2006 | WO2006023381A1 Pyrimidinone compounds |
| 03/01/2006 | EP1462451B1 Novel crystalline forms of meloxicam and the preparation and interconversion methods thereof |
| 02/23/2006 | US20060040928 amyloid precursor protein and gamma -secretase inhibitor; 3,4,6,7,8,9-Hexahydro-2-methyl-3-oxo-2H-naphtho[2,3-e]-1,2-thiazine-4-carboxanilide 1,1-dioxide; neurodegenerative disease: Alzheimer's disease, amyloid plaque, Parkinson's disease, Down's syndrome, hemorrhage, arteriosclerosis |
| 02/23/2006 | DE102005035588A1 Compound containing different multiple bonds of nitrogen-nitrogen double bond useful in preparation of anisotropic polymer film, anisotropy in isotropic material or for reinforcement of anisotropy is new |
| 02/22/2006 | CN1738807A Substituted aralkyl derivatives |
| 02/22/2006 | CN1738799A Methods for preparing phenylalkyne derivatives |
| 02/22/2006 | CN1242990C Red light emitted compound used for organic electroluminous device and orgainic electroluminous device using same |
| 02/16/2006 | US20060034832 Cell death inhibitor |
| 02/15/2006 | CN1735592A Hydroxyethylamine derivatives for the treatment of alzheimer's disease |
| 02/09/2006 | WO2006014405A2 Sulfonamide-based compounds as protein tyrosine kinase inhibitors |
| 02/09/2006 | WO2006014207A1 Prostaglandin analogs |
| 02/09/2006 | US20060030599 Sulphonamide derivatives |
| 02/09/2006 | CA2571786A1 Prostaglandin analogs |
| 02/08/2006 | EP1622885A2 Dihydrothiazine prodrugs of thiazolium agents |
| 02/07/2006 | US6995183 Adamantylglycine-based inhibitors of dipeptidyl peptidase IV and methods |
| 02/02/2006 | US20060025459 Having Asp2 ( beta -secretase, BACE1 or Memapsin) inhibitory activity, for therapy of diseases characterised by elevated beta -amyloid levels or beta -amyloid deposits |
| 02/02/2006 | US20060025408 Process for the preparation of crystalline form-1 of 4-hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2H-1,2-benzothiazine-3-carboxamide-1,1-dioxide |
| 02/02/2006 | US20060024523 Organic electroluminescence device |
| 02/01/2006 | EP1620434A1 Fused bicyclic-substituted amines as histamine-3 receptor ligands |
| 02/01/2006 | CN1727348A Derivant of cephalosporin alkene, and preparation method |
| 02/01/2006 | CN1239497C Intermediate product for preparing aralkyl and aryl alkylene heterocyclic lactam and imide |
| 01/31/2006 | US6992082 for treatment of cellular proliferative diseases such as cancer, hyperplasias, restenosis, cardiac hypertrophy, immune disorders and inflammation |
| 01/25/2006 | EP1619230A1 Red light emitting compounds for organic electroluminescent devices and organic electroluminescent devices using them |
| 01/19/2006 | US20060014736 Phenothiazine kinesin inhibitors |
| 01/19/2006 | US20060014216 Prophylaxis, therapy of Alzheimer's disease; using phenothiazine compound such as methylene blue |
| 01/19/2006 | CA2581674A1 Indoleamine 2,3-dioxygenase (ido) inhibitors |
| 01/12/2006 | WO2005117847A3 Methods and compounds for the treatment of neoplasms |
| 01/12/2006 | US20060009448 Metabolites of 4-(3,4-dichloro-phenyl)-2-[2-(4-methyl-piperazin-1-yl)-benzylidene]thiomorpholin-3-one |
| 01/11/2006 | EP1613621A1 Prostaglandin analogs as ep4 receptor agonists |
| 01/11/2006 | EP1613319A2 Substituted phenyl acetamides and their use as protease inhibitors |
| 01/11/2006 | CN1235889C Cyanomethylene compounds, process for producing the same, and agricultural or horticultural bactericide |
| 01/10/2006 | US6984640 Antiparasitic artemisinin derivatives (endoperoxides) |
| 01/10/2006 | US6984639 such as (2S)-3,3-dimethyl-1-[2-(5-phenylpentanoyl) pyrrolidinyl]pentane-1,2-dione which has affinity for immunophilin; for treatment of neurological disorders/neurodegenerative diseases; nerve growth factors; FK binding proteins |
| 01/10/2006 | US6983612 Process for producing phenothiazine granules |
| 01/05/2006 | WO2006002441A1 Phenothiazine derivatives and their method of use |
| 01/05/2006 | US20060004197 Sulfonamide-based compounds as protein tyrosine kinase inhibitors |
| 01/05/2006 | US20060002850 Radiolabeled lymphatic staining agents and methods for making |
| 01/05/2006 | CA2574206A1 Phenothiazine derivatives and their method of use |
| 01/04/2006 | CN1717395A Reactive materials for limited play optical devices and methods of making same |
| 01/03/2006 | US6982261 A progesterone receptor antagonist for providing progestational therapy, treating cancer of breast, uterine, ovarian, endometrial, or prostate, providing contraceptives, hormone replacement therapy |
| 12/29/2005 | WO2005123933A1 Enzymatic deacetylation of a phenoxy-alkynyl acetate |
| 12/29/2005 | WO2005123706A1 Crystalline polymorphs of (3s)-n-hydroxy-4({4-[(4-hydroxy-2-butynyl)oxy]phenyl}sulfonyl)-2,2-dimethyl-3-thiomorpholine carboxamide |
| 12/29/2005 | WO2005123705A1 Method for preparing hydroxamic acids |
| 12/29/2005 | US20050288279 Phenothiazine derivatives and their method of use |
| 12/28/2005 | EP1609362A2 Non-systemic control of parasites |
| 12/28/2005 | EP1608619A1 Muscarinic agonists |
| 12/22/2005 | WO2005121073A1 Inhibitors of histone deacetylase |
| 12/22/2005 | US20050282905 Hydroxamic acid derivative and mmp inhibitor containing the same as active ingredient |
| 12/21/2005 | EP1607393A1 Compositions comprising hydroalkylated direct dyestuffs, process for implementing and use |
| 12/15/2005 | WO2005117847A2 Methods and compounds for the treatment of neoplasms |
| 12/15/2005 | US20050277635 Method of treating diseases and conditions associated with an altered level of amyloid beta peptides and new enolcarboxamide compounds |
| 12/15/2005 | US20050277632 2-Hydroxyethylamines 2-substituted by a hydroxy-N-heterocycle and N-substituted by an omega-phenyl-1,1-dimethylalkyl group: 6-hydroxy-8-{1-hydroxy-2-[2-(4-methoxy-phenyl)-1,1-dimethyl-ethylamino]-ethyl}-2,2-dimethyl-4H-benzo[1,4]oxazin-3-one; betamimetics |
| 12/13/2005 | CA2280151C Arylsulfonyl hydroxamic acid derivatives |
| 12/08/2005 | US20050272929 Apratastat; tumor necrosis factor-alpha-associated disorders; antiinflammatory, antiarthritic agents, antipyretics, transplant rejection, cachexia, insulin resistance, septic shock, congestive heart failure, central nervous system disorders, inflammatory bowel disease, HIV infections |
| 12/08/2005 | US20050272928 Coupling a silyl ester of (3S)-2,2-dimethyl-tetrahydro-2H-1,4-thiazine-3-carboxylic acid with 6,4-[4-(chlorosulfonyl)phenoxy]-2-butynyl acetate, hydrolyzing the silyl ester |
| 12/08/2005 | US20050272725 Mixture of water, solvent, cosolvent and lipase used for hydrolyzing ester bond; specific, high yield and purity; performed at moderate temperatures and pH |
| 12/07/2005 | EP1601643A1 Arylcycloalkyl derivatives with branched side chains as ppar receptor modulators, method for their production and their use as medicaments |
| 12/07/2005 | CN1705649A Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents |
| 12/01/2005 | WO2005113526A2 Metabolites of 4-(3,4-dichloro-phenyl)-2-[2-(4-methyl-piperazin-1-yl)-benzylidene]-thiomorpholin-3-one |
| 12/01/2005 | WO2005113525A1 N, n’-substituted-1,3-diamino-2-oxopropane derivatives, their pharmaceutical compositions and use |
| 12/01/2005 | WO2005113524A1 Fluorescent method and compounds to monitor protein-lipid binding |
| 12/01/2005 | US20050266329 Organophotoreceptor comprises an electrically conductive substrate and a photoconductive element; electrophotography |
| 11/30/2005 | EP1600821A1 Bridged charge transport materials having a central sulfur atom linkage |
| 11/30/2005 | CN1702563A Bridged charge transport materials having a central sulfur atom linkage |
| 11/30/2005 | CN1229323C Dialkoyl-halogen phenyl substituted keto-enol |
| 11/24/2005 | WO2005110422A2 Treatment of diseases associated with altered level of amyloid beta peptides |
| 11/24/2005 | CA2567223A1 Treatment of diseases associated with altered level of amyloid beta peptides |
| 11/23/2005 | EP1423151A4 Light-stabilized $i(in vivo) stain composition and method of manufacture |
| 11/16/2005 | EP1595872A1 Fluorescent compounds for monitoring protein-lipid binding |
| 11/16/2005 | CN1227244C Herbicidal benzoyl derivatives |
| 11/09/2005 | EP1009731B1 Method for producing aryloligoamines |
| 11/03/2005 | WO2005102989A1 Non-nucleoside reverse transcriptase inhibitors |
| 11/03/2005 | WO2005044201A3 Ph sensitive prodrugs of 2,6-diisopropylphenol |
| 11/03/2005 | WO2005011611A3 Bicyclic compounds and compositions as pdf inhibitors |
| 11/03/2005 | CA2563826A1 Treatment of cns disorders using cns target modulators |
| 11/03/2005 | CA2563180A1 Non-nucleoside reverse transcriptase inhibitors |
| 11/02/2005 | CN1692098A Sulfonamide derivatives, insecticides for agricultural and horticultural use, and usage thereof |
| 10/27/2005 | WO2005100333A1 Methods and intermediates for the synthesis of delta-9 tetrahydrocannabinol |
| 10/27/2005 | WO2005100318A1 Alkanoic acids and their esters as antidiabetic agents |
| 10/26/2005 | EP1587786A1 2.4-DIHALOGEN-6-(C sb 2 /sb -C sb 3 /sb -ALKYL)-PHENYL SUBSTITUTED TETRAMIC ACID DERIVATIVES |
| 10/26/2005 | EP1427408A4 CYCLIC HYDROXAMIC ACIDS AS INHIBITORS OF MATRIX METALLOPROTEINASES AND/OR TNF-$g(a) CONVERTING ENZYME (TACE) |